Report Company Directory
- Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution Proposal by GlobeNewsWire
- Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders by GlobeNewsWire
- Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal by GlobeNewsWire
- Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC by GlobeNewsWire
- Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities by GlobeNewsWire
- Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI by GlobeNewsWire
- Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives by GlobeNewsWire
- Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258 by GlobeNewsWire
- Vincerx Pharma, Inc. Announces Reverse Stock Split by GlobeNewsWire
- Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc. by GlobeNewsWire